Ipamorelin 5mg × 10 vials

A selective growth hormone secretagogue studied for growth hormone release, ghrelin receptor activity, pituitary signaling, IGF-1-related pathways, recovery research, sleep-related protocols, and body composition support studies.

Product Overview

Compound: Ipamorelin
Strength: 5 mg per vial
Injection type: Subcutaneous
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Notes

Ipamorelin is described in published research as a selective growth hormone secretagogue and ghrelin receptor agonist. It has been studied for growth hormone release, pituitary response, IGF-1-related pathways, recovery-related protocols, and broader endocrine research.

Compared with some older growth hormone-releasing peptides, ipamorelin has been studied for a more selective GH-release profile.

No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.